cap
associ
signific
morbid
mortal
consider
cost
care
unit
state
cap
frequent
caus
death
result
infecti
diseas
eighth
lead
caus
death
overal
mortal
rate
patient
treat
outpati
basi
requir
admiss
hospit
averag
increas
sever
cap
requir
admiss
intens
care
unit
icu
overal
rate
cap
rang
per
person
per
year
highest
rate
extrem
age
case
occur
winter
month
econom
cost
exce
billion
year
primari
rout
pathogen
lung
microaspir
upper
airway
content
although
respiratori
tract
constantli
expos
particul
materi
lower
airway
usual
steril
pulmonari
defens
mechan
includ
anatomi
nasal
passag
cough
reflex
ciliari
respiratori
epithelium
humer
cellular
factor
eg
immunoglobulin
complement
macrophag
neutrophil
cap
occur
defect
host
defens
exposur
particularli
virul
microorgan
overwhelm
inoculum
rout
pathogen
lung
hematogen
spread
direct
spread
contigu
focu
macroaspir
sever
predispos
condit
box
bacteria
reach
lung
caus
inflammatori
respons
result
diseas
best
studi
pneumonia
absenc
opson
antibodi
rapidli
multipli
alveolar
space
lead
local
hyperemia
edema
mobil
neutrophil
fill
alveoli
bacteria
red
cell
fluid
lead
signific
increas
weight
lung
earli
phase
consolid
figur
subsequ
lead
advanc
consolid
increas
neutrophil
pulmonari
cell
fibrin
although
numer
pathogen
associ
caus
cap
limit
rang
key
pathogen
caus
major
case
tabl
predomin
pathogen
continu
pneumonia
pneumococcu
account
approxim
two
third
case
bacterem
pneumonia
caus
agent
includ
limit
h
influenza
pneumonia
c
pneumonia
legionella
speci
enter
gramneg
bacteria
enterobacteriacea
pseudomona
aeruginosa
aureu
anaerob
aspir
pneumonia
respiratori
virus
influenza
adenoviru
respiratori
syncyti
viru
parainfluenza
coronaviru
aureu
figur
gramneg
bacilli
klebsiella
speci
figur
less
frequent
isol
caus
select
patient
eg
patient
sever
cap
requir
intens
care
admiss
recent
receiv
antimicrobi
therapi
pulmonari
comorbid
frequenc
causesfor
exampl
mycobacterium
tuberculosi
c
psittaci
psittacosi
coxiella
burnettii
q
fever
francisella
tularensi
tularemia
endem
fungi
histoplasmosi
coccidioidomycosi
blastomycosi
vari
epidemiolog
set
recent
communityassoci
methicillinresist
aureu
camrsa
strain
emerg
caus
sever
cap
associ
hemorrhag
necrot
complic
usual
follow
influenza
infect
camrsa
virul
tradit
nosocomi
mrsa
strain
strain
camrsa
tend
suscept
antimicrobi
agent
hospitalacquir
mrsa
strain
major
camrsa
strain
contain
novel
type
iv
staphylococc
cassett
chromosom
sccmec
gene
also
carri
pantonvalentin
leukocidin
pvl
gene
produc
toxin
creat
lytic
pore
cell
membran
neutrophil
induc
releas
chemotact
factor
promot
inflamm
tissu
destruct
patient
often
necrot
pneumonia
abscess
see
figur
although
pvl
toxin
may
highli
link
epidemiolog
marker
camrsa
strain
remain
unclear
whether
pvl
major
virul
determin
camrsa
previou
month
alcohol
medic
comorbid
immunosuppress
ill
therapi
exposur
child
daycar
center
avail
data
suggest
clinic
relev
level
penicillin
resist
minimum
inhibitori
concentr
mic
mcgml
breakpoint
rate
penicillin
resist
pneumonia
locat
north
america
symptom
sign
cap
includ
cough
either
product
nonproduct
pleurit
chest
pain
short
breath
temperatur
higher
c
crackl
auscult
mucopurul
sputum
product
frequent
found
associ
bacteri
pneumonia
wherea
scant
wateri
sputum
product
suggest
atyp
pathogen
although
classic
descript
certain
type
sputum
product
particular
pathogen
eg
pneumococc
pneumonia
rustcolor
sputum
clinic
descript
usual
help
initi
clinic
decis
make
regard
treatment
clinic
present
specif
pathogen
variabl
gastrointestin
symptom
nausea
vomit
diarrhea
mental
statu
chang
may
accompani
respiratori
manifest
physic
examin
major
patient
febril
although
find
frequent
absent
older
patient
increas
respiratori
rate
frequent
note
may
antimicrobi
resist
especi
emerg
multidrugresist
pneumonia
escal
worldwid
last
two
decad
risk
factor
drugresist
pneumonia
includ
young
age
year
old
age
year
macrolid
fluoroquinolon
therapi
within
gram
stain
sputum
contain
klebsiella
pneumonia
organ
sensit
sign
elderli
patient
tachycardia
also
common
chest
examin
reveal
audibl
rale
patient
approxim
one
third
evid
consolid
howev
clear
constel
symptom
sign
found
accur
predict
whether
patient
pneumonia
major
blood
test
abnorm
leukocytosi
typic
per
mm
leftward
shift
leukopenia
occur
gener
associ
poor
prognosi
adult
patient
immunocompet
evalu
pneumonia
demonstr
sign
includ
cough
sputum
product
labor
breath
includ
alter
breath
sound
rale
andor
fever
symptom
especi
cough
nonspecif
may
also
present
patient
diseas
consid
differenti
diagnosi
box
figur
presenc
infiltr
plain
chest
radiograph
consid
gold
standard
diagnos
pneumonia
clinic
featur
support
radiologist
reliabl
differenti
bacteri
nonbacteri
pneumonia
basi
radiograph
appear
comput
tomographi
ct
scan
significantli
sensit
detect
pulmonari
infiltr
patient
hospit
cap
clinic
signific
find
unclear
site
care
patient
cap
affect
overal
cost
treatment
intens
diagnost
test
empir
antimicrobi
gener
consensu
major
patient
safe
treat
outpati
howev
select
patient
hospit
base
requir
care
eg
need
close
observ
respiratori
support
intraven
antibiot
concern
advantag
mortal
predict
tool
also
help
guid
clinician
determin
requir
hospit
pneumonia
predict
rule
develop
year
ago
offer
import
insight
risk
mortal
techniqu
use
combin
demograph
variabl
comorbid
physic
observ
laboratori
radiograph
variabl
assign
patient
one
five
class
belong
pneumonia
sever
index
psi
class
low
risk
mortal
treat
outpati
psi
class
slightli
higher
risk
mortal
may
requir
brief
observ
stay
hospit
psi
class
highest
mortal
risk
requir
hospit
psi
class
admit
icu
though
port
predict
rule
effect
determin
mortal
risk
practic
approach
clinic
set
partli
base
laboratori
evalu
timeconsum
rule
use
five
aspect
make
clinic
determinationconfus
urea
concentr
respiratori
rate
blood
pressur
age
meet
two
criteria
consid
hospit
howev
method
requir
blood
sampl
laboratori
analysi
urea
concentr
respons
design
omit
blood
urea
measur
practic
officebas
set
score
equat
home
treatment
score
hospitalsupervis
treatment
score
hospit
recommend
regard
admiss
icu
provid
infecti
diseas
societi
america
idsa
american
thorac
societi
at
guidelin
manag
cap
accord
idsaat
guidelin
direct
admiss
icu
essenti
patient
septic
shock
requir
vasopressor
patient
acut
respiratori
failur
requir
intub
mechan
ventil
icu
admiss
also
consid
patient
three
follow
confus
disorient
uremia
blood
urea
nitrogen
mgdl
respiratori
rate
breathsmin
hypotens
requir
aggress
fluid
resuscit
pao
fio
ratio
multilobar
infiltr
leukopenia
white
blood
count
cellsmm
thrombocytopenia
platelet
count
cellsmm
hypothermia
core
temperatur
c
util
diagnost
studi
determin
caus
agent
cap
controversi
lack
rapid
easili
perform
accur
costeffect
method
allow
immedi
result
major
patient
point
servic
ie
initi
evalu
clinician
offic
acut
care
set
nevertheless
good
rational
establish
caus
diagnosi
ie
permit
antibiot
select
permit
optim
select
agent
specif
pathogen
limit
consequ
antibiot
misus
identifi
pathogen
potenti
epidemiolog
signific
legionella
tuberculosi
tb
routin
microbiolog
test
recommend
recent
guidelin
patient
manag
commun
howev
patient
purul
sputum
reason
send
sampl
laboratori
gram
stain
cultur
basi
inform
may
valu
direct
specif
therapi
patient
condit
fail
respond
initi
empir
therapi
investig
variabl
recommend
patient
requir
admiss
includ
blood
cultur
gram
stain
cultur
thoracentesi
signific
pleural
fluid
present
approxim
patient
cap
posit
blood
cultur
commonli
associ
sever
ill
falseposit
blood
cultur
may
common
pathogenposit
blood
cultur
patient
admit
gener
ward
may
limit
benefit
patient
consid
option
recent
guidelin
sever
ill
patient
requir
icu
admiss
blood
cultur
may
increas
likelihood
find
pathogen
cover
customari
antimicrobi
therapi
recommend
patient
valu
perform
sputum
gram
stain
cultur
limit
fact
mani
patient
produc
good
specimen
valid
gram
stain
relat
directli
experi
interpret
howev
stringent
criteria
appli
specif
pneumococc
pneumonia
approach
sputum
cultur
pathogen
eg
legionella
speci
fungu
viru
mycobacterium
speci
obtain
base
epidemiolog
consider
tuberculosi
consid
asthma
postnas
drip
vagal
irrit
patient
endem
area
chest
radiograph
show
upper
lobe
cavitari
infiltr
patient
prolong
symptom
cough
often
weight
loss
night
sweat
patient
homeless
histori
exposur
tb
earli
administr
therapi
import
outcom
cap
attempt
obtain
expector
sputum
never
delay
prompt
initi
antimicrobi
therapi
test
consid
help
patient
admit
hospit
includ
urinari
antigen
assay
legionella
pneumonia
direct
stain
ie
acidfast
detect
mycobacteri
infect
patient
epidemiolog
risk
tb
mani
rapid
diagnost
test
nucleic
acid
amplif
test
ie
polymeras
chain
reaction
pcr
assay
earli
develop
commonli
avail
offer
promis
rapid
diagnosi
like
becom
increasingli
util
futur
serolog
test
gener
help
earli
manag
cap
determin
acut
convalesc
titer
requir
caus
ascrib
specif
pathogen
percutan
transthorac
needl
aspir
ptna
invas
test
includ
bronchoscopi
biopsi
routin
recommend
evalu
patient
may
valuabl
immunocompromis
host
suspect
tb
absenc
product
cough
select
case
chronic
pneumonia
pneumonia
associ
suspect
neoplasm
foreign
bodi
suspect
pneumocysti
carinii
pneumonia
case
intub
requir
suspect
condit
requir
lung
biopsi
respiratori
fluoroquinolon
recommend
patient
sever
cap
requir
icu
admiss
recommend
given
base
risk
pseudomona
andor
camrsa
pseudomona
uncommon
caus
cap
consid
follow
risk
factor
histori
bronchiectasi
advanc
chronic
obstruct
pulmonari
diseas
frequent
use
antimicrobi
steroid
camrsa
consider
linezolid
vancomycin
ad
regimen
although
methicillinresist
strain
aureu
still
minor
excess
mortal
inappropri
antibiot
therapi
would
suggest
empir
coverag
consid
camrsa
concern
best
indic
aureu
presenc
gramposit
cocci
cluster
tracheal
aspir
adequ
sputum
sampl
see
figur
clinic
risk
factor
aureu
cap
includ
endstag
renal
diseas
intraven
drug
abus
prior
influenza
prior
antibiot
especi
fluoroquinolon
treatment
option
obvious
simplifi
caus
agent
establish
strongli
suspect
box
diagnost
procedur
provid
identif
specif
caus
within
hour
still
use
guid
continu
therapi
better
rapid
diagnost
method
major
patient
treat
empir
although
author
propos
syndrom
approach
therapi
count
predict
caus
base
present
clinic
manifest
data
indic
present
clinic
featur
specif
enough
reliabl
predict
caus
cap
therefor
unless
specif
epidemiolog
factor
eg
influenza
epidem
empir
approach
initi
therapi
usual
base
likelihood
one
key
pathogen
respons
diseas
recent
publish
guidelin
north
america
give
specif
recommend
empir
therapi
cap
tabl
outpati
empir
therapi
macrolid
doxycyclin
antipneumococc
fluoroquinolon
eg
levofloxacin
gemifloxacin
moxifloxacin
combin
plu
macrolid
recommend
treatment
option
base
risk
factor
recent
antimicrobi
use
comorbid
gener
inpati
treatment
combin
therapi
cefotaxim
ceftriaxon
ertapenem
ampicillinsulbactam
plu
azithromycin
monotherapi
patient
treat
minimum
day
long
afebril
hour
clinic
stabl
rel
baselin
statu
longer
durat
therapi
recommend
patient
bacterem
aureu
pneumonia
risk
associ
endocard
deepseat
infect
patient
extrapulmonari
infect
especi
mening
patient
p
aeruginosa
pneumonia
patient
infect
caus
less
common
pathogen
potenti
benefit
therapi
shorter
day
includ
improv
patient
complianc
reduct
microbi
resist
cost
advers
event
clostridium
difficil
infect
patient
fever
reduc
within
day
therapi
howev
cough
fatigu
often
persist
sever
week
even
patient
mild
diseas
symptom
expect
last
longer
serious
ill
patient
inform
impart
patient
better
awar
ill
anticip
clinic
cours
patient
may
respond
appropri
initi
antibiot
therapi
nonrespons
defin
absenc
delay
achiev
clinic
stabil
within
sever
day
actual
clinic
deterior
number
possibl
infecti
noninfecti
consid
tabl
systemat
assess
patient
take
consider
account
common
caus
treatment
failur
lack
delay
respons
host
despit
appropri
antibiot
infect
organ
cover
initi
antibiot
regimen
antibiot
chang
time
period
consid
patient
deterior
new
cultur
data
epidemiolog
clue
suggest
altern
caus
vaccin
target
pneumococc
diseas
influenza
mainstay
prevent
cap
pneumococc
polysaccharid
vaccin
inactiv
liveattenu
influenza
vaccin
consid
patient
accord
recent
recommend
center
diseas
control
prevent
cdc
chemoprophylaxi
ie
oseltamivir
zanamivir
use
adjunct
influenza
vaccin
clinician
also
interven
modifi
associ
risk
factor
pneumonia
adult
smoke
signific
risk
factor
cap
smoke
cessat
attempt
particularli
import
relev
patient
hospit
pneumonia
addit
stabil
underli
condit
eg
congest
heart
failur
diabet
promot
appropri
nutrit
may
help
reduc
risk
cap
therebi
promot
longer
healthier
live
